Abstract
The incidence of cutaneous malignant melanoma is increasing worldwide, resulting in the demand for clinically useful prognostic biomarkers, especially for invasive and metastatic disease. We studied the immunohistochemical expression of interleukin-17 (IL-17), IL-23, and p73 in 35 malignant melanomas and compared them with benign melanocytic nevi and Spitz nevi, correlating them with clinical-pathological variables. A higher and statistically significant difference (P<0.05) in the intensity and percentage of stained cells of IL-17 and IL-23 was found in the melanoma group than in ordinary benign nevi that did not correlate with Breslow thickness nor Clark level. Moreover, p73 staining and percentage of stained cells was significantly higher (P<0.05) in all the melanomas studied, with a peculiar cytoplasmatic distribution. Our findings could suggest a possible IL-17, IL-23, and p73 involvement in cutaneous melanomas with a hypothetical impact on melanoma invasiveness.
References
Feb 1, 1984·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J L CordellD Y Mason
Jul 9, 1999·Immunology Letters·F PagesW H Fridman
Dec 15, 2000·Immunity·B OppmannR A Kastelein
Apr 13, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mirko MarabeseMassimo Broggini
Dec 1, 2007·The Journal of Investigative Dermatology·Chunying LiQingyi Wei
Jul 29, 2008·Biochemical and Biophysical Research Communications·Bin ZhangGuoen Fang
May 28, 2009·Blood·Ilona KryczekWeiping Zou
Jul 1, 2009·The Journal of Experimental Medicine·Lin WangHua Yu
Dec 5, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Claus GarbeAlexander Eggermont
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Mar 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ilona KryczekWeiping Zou
Aug 29, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Maio
Jan 29, 2013·Ear, Nose, & Throat Journal·Calvin WeiBeverly Y Wang
Mar 13, 2014·Inflammation·Jun LiHongda Lu
Mar 29, 2014·Cancer Investigation·Paul ZarogoulidisKonstantinos Zarogoulidis
Apr 29, 2014·Molecular and Clinical Oncology·Meng YangJianmin Li
May 3, 2014·Acta Dermato-venereologica·Giulia GanzettiAnnamaria Offidani
Aug 3, 2014·Cold Spring Harbor Perspectives in Medicine·Vladimir A Botchkarev, Elsa R Flores
Citations
May 14, 2016·Schizophrenia Bulletin·James S Brown
Dec 13, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·N RodríguezG Domínguez
Jul 19, 2017·Cold Spring Harbor Perspectives in Biology·Juming YanMichele W L Teng
Aug 23, 2017·PloS One·Cristina PellegriniMaria Concetta Fargnoli
Feb 9, 2018·Melanoma Research·Giulia GanzettiMonica Emanuelli
Jul 25, 2019·Bioscience Reports·Hui Ye, Xia Guo
Dec 3, 2015·Cancer Medicine·Zheng Bo HuHai Lu
Oct 31, 2019·International Journal of Dermatology·Nicoletta BernardiniConcetta Potenza
Aug 30, 2019·Scientific Reports·Petar OzretićNeda Slade
Nov 3, 2020·Frontiers in Genetics·Yanhong ShouJinhua Xu
Feb 5, 2021·Dermatopathology·Oriana SimonettiAnnamaria Offidani
Dec 2, 2020·The Journal of Allergy and Clinical Immunology·Raquel Castillo-GonzálezFrancisco Sánchez-Madrid